Tokyo, Japan

Ken-ichi Saito

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mitsubishi Pharma Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ken-ichi Saito. Retrieved from https://idiyas.com/inventor/ken-ichi-saito-nzys65p2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ken-ichi Saito: Innovator in Medicinal Chemistry

Introduction

Ken-ichi Saito is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on cyclic amide derivatives. His research focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Ken-ichi Saito holds a patent for cyclic amide derivatives, which are represented by a specific formula. These compounds act as ligands to sigma receptors and can be utilized as active ingredients in medicaments. The patent details various structural components, including alkyl groups, aryl groups, and heterocyclic groups, which contribute to the functionality of these compounds.

Career Highlights

Saito is currently affiliated with Mitsubishi Pharma Corporation, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential impact on drug development and therapeutic interventions.

Collaborations

Throughout his career, Ken-ichi Saito has collaborated with notable colleagues, including Haruko Yamabe and Masahiro Okuyama. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Ken-ichi Saito's contributions to the field of medicinal chemistry through his patented innovations exemplify the importance of research in developing new therapeutic agents. His work continues to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…